India IVF secures $1.25 million pre-series a funding from Tomorrow Capital for north India expansion

India IVF, one of India’s pioneering tech-enabled fertility platforms, has secured $1.25 million in pre-Series A funding from Tomorrow Capital, a venture capital fund with a $100 million focus on early-stage consumer healthcare businesses. Founded in 2014 by Dr Richika Sahay and Dr Somendra Shukla, India IVF has operated profitably across its five centres in North India, including clinics in Delhi NCR and Srinagar. This funding marks the platform’s first external investment since its inception and will drive expansion to increase fertility care accessibility across North India.

India IVF has developed India’s first tech-enabled fertility platform, aiming to bring comprehensive fertility care through advanced technology and a dedicated team. The funding will enable India IVF to reach underserved communities, bridging gaps in access to advanced fertility solutions. Tomorrow Capital’s investment comes after its recent support for other healthcare ventures, VitusCare and IndiShreshtha, reinforcing its commitment to specialised healthcare businesses.

Rahul Saha, Senior Principal at Tomorrow Capital, expressed support for India IVF’s mission, stating, “India IVF has shown remarkable growth and a deep understanding of the unique fertility challenges faced by many Indian couples. With a tech-enabled, patient-focused approach, they deliver high-quality personalised care, addressing the often-emotional & stigma attached journey of the fertility treatment. Tomorrow Capital backs ventures that drive meaningful impact, and with India IVF, we’re proud to enable access to essential fertility care across underserved regions in India. We believe their innovative approach will set new standards in India’s fertility sector, and we are excited to support their mission to make fertility care more accessible across the country.”

Dr Somendra Shukla, Co-Founder and CEO of India IVF, remarked on the partnership’s potential impact, saying, “This partnership will empower us to expand our network and bring advanced fertility solutions to more communities. We look forward to making a positive impact on more families and growing India IVF into a trusted national brand.”

Dr Richika Sahay, Co-Founder and Medical Director, highlighted the scale of infertility issues in India, noting, “Approximately 30 million couples in India suffer from infertility, yet only 10 per cent receive proper treatment due to limited access to fertility care. Our mission is to leverage technology and innovation to deliver quality, affordable, and empathetic fertility care to everyone. With Tomorrow Capital’s support, we are well-positioned to expand access to fertility care across North India.”

With this funding, India IVF aims to reshape fertility care access across North India, providing support for couples in underrepresented regions. Through its technology-driven, patient-centred approach, India IVF seeks to redefine fertility care standards, making high-quality treatment more accessible and helping couples across North India in their journeys toward parenthood.